You are here

  • Home
  • Archive
  • Volume 3, Issue Suppl 2
  • Anticancer effect obtained against MCA205 sarcoma following treatment with the oncolytic peptide LTX-315 in combination with immune checkpoint inhibitors

Article info

Article menu

Download PDFPDF

Poster Presentation
Anticancer effect obtained against MCA205 sarcoma following treatment with the oncolytic peptide LTX-315 in combination with immune checkpoint inhibitors
Free

Authors

Citation

Rekdal Ö, Yamazaki T, Sveinbjornsson B, et al
Anticancer effect obtained against MCA205 sarcoma following treatment with the oncolytic peptide LTX-315 in combination with immune checkpoint inhibitors
Journal for ImmunoTherapy of Cancer 2015;3:P375. doi: 10.1186/2051-1426-3-S2-P375

Publication history

  • First published November 4, 2015.
Online issue publication 
March 11, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). 2015